2 dividend growth stocks I’d consider buying in May

These two shares could offer a potent mix of dividend growth and low valuations.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With inflation continuing to rise and forecast to move higher, stocks offering high levels of dividend growth could become more attractive to investors. In other words, a high yield may be insufficient if inflation remains stubbornly high over the medium term. Therefore, buying companies with low payout ratios and earnings growth potential could be a sound strategy. Here are two prime examples which could be worth buying today.

Mixed performance

Reporting on Thursday was specialist risk insurer Beazley (LSE: BEZ). Its trading statement for the first quarter of 2017 showed it has made a good start to the year, although its gross written premiums fell by 2%. Its premium rates on renewal business decreased by 1%, which is generally in line with the company’s expectations.

Looking ahead, Beazley has clear growth potential. Its recent acquisition of Creechurch Underwriters expands its speciality lines presence in Canada. This forms part of what appears to be a sound strategy to develop its non-US speciality lines business. Alongside this, the company will continue to focus on growth in the US, while also reorganising its life, accident and health business as well as political risks and contingency divisions. They will come together and could deliver synergies and improving profitability in the long run.

With Beazley trading on a price-to-earnings (P/E) ratio of 14.8, it seems to offer value for money at the present time. It yields 3%, which is 80 basis points lower than the FTSE 100’s dividend yield. However, with the company’s dividends being covered 2.3 times by profit, there appears to be scope for growth over the long term. Together with an upbeat outlook for the business given the changes it is making, now could be the right time to buy it.

Growth at a reasonable price

Also offering scope for higher dividends in future years is diversified property and casualty reinsurance specialist Novae Group (LSE: NVA). It currently pays out just 40% of its profit as a dividend. This figure could increase in future years and still provide the business with sufficient capital through which to invest for growth. As such, it would be unsurprising for dividend growth to at least match profit growth over the medium term.

Novae Group is forecast to record a rise in its bottom line of 17% in the current year, followed by further growth of 33% next year. This suggests a double-digit rise in shareholder payouts is on the cards. This could help to make the company’s dividend appeal much higher – especially since it currently has a rather lowly yield of 2.6%.

With Novae Group trading on a P/E ratio of 17.8, it seems to offer upside potential. When its rating is combined with the aforementioned growth rates, it equates to a price-to-earnings growth (PEG) ratio of just 0.7. This suggests that as well as strong income potential, it also offers scope for a significantly higher valuation.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

If I’d put £5,000 in Nvidia stock at the start of 2024, here’s what I’d have now

Nvidia stock was a massive winner in 2023 as the AI chipmaker’s profits surged across the year. How has it…

Read more »

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »

Young black woman using a mobile phone in a transport facility
Market Movers

Meta stock slumps 13% after poor results. Here’s what I’ll do

Jon Smith flags up the reasons behind the fall in the Meta stock price overnight, along with his take on…

Read more »